Business Context and Reporting Period
This Form 8-K Current Report was filed by cbdMD, Inc. on March 4, 2021, covering events occurring on March 3, 2021. The company is incorporated in North Carolina and trades on the NYSE American under the symbols YCBD and YCBDpA. It is classified as an emerging growth company.
Key Financial Metrics
This filing is a current report regarding corporate governance and executive appointments. It does not provide financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. No financial data is present in this document.
Material Changes
The primary material change reported is an expansion of executive leadership responsibilities:
- Executive Appointment: T. Ronan Kennedy, who joined as Chief Executive Officer on October 1, 2020, was appointed by the Board of Directors to also serve as Chief Operating Officer, effective March 3, 2021.
- Contractual Amendment: The company entered into Amendment No. 1 to Mr. Kennedy's Executive Employment Agreement to reflect this additional role.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding financial guidance, future outlook, specific risks, contingencies, or unusual items. The document is strictly limited to the disclosure of the officer appointment and the associated employment agreement amendment.
Investor Verification Checklist
- Verify the terms of Amendment No. 1 to the Executive Employment Agreement (filed as Exhibit 10.1) to understand any changes in compensation or duties.
- Confirm the dual reporting structure where T. Ronan Kennedy serves as both CEO and COO.
- Review subsequent filings (e.g., 10-Q or 10-K) for the actual financial performance and liquidity status, as this 8-K contains no financial data.